https://medicaex.com/businesswire/seagen-announces-u-s-fda-approval-of-new-indication-for-adcetris-brentuximab-vedotin-for-children-with-previously-untreated-high-risk-hodgkin-lymphoma/ 2022-11-10T19:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Seagen_Logo_RGB-wpH5WJ.jpeg https://medicaex.com/businesswire/gigxr-holoscenarios-named-to-times-list-of-the-best-inventions-of-2022-recognizes-holographic-patient-simulation-as-life-changing-innovation/ 2022-11-10T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Unknown-w07Ynt.jpeg https://medicaex.com/businesswire/cg-oncology-presents-new-phase-2-data-with-cg0070-in-combination-with-keytruda-pembrolizumab-in-non-muscle-invasive-bladder-cancer-unresponsive-to-bacillus-calmette-guerin-2/ 2022-11-10T18:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/CG_Logo_color-FIPn4f.jpeg https://medicaex.com/businesswire/insights-on-the-celiac-disease-drugs-global-market-to-2027-rising-rd-activities-to-introduce-advanced-celiac-disease-drugs-presents-opportunities-researchandmarkets-com/ 2022-11-10T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Qgmi6F.jpeg https://medicaex.com/businesswire/cg-oncology-presents-new-phase-2-data-with-cg0070-in-combination-with-keytruda-pembrolizumab-in-non-muscle-invasive-bladder-cancer-unresponsive-to-bacillus-calmette-guerin/ 2022-11-10T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/CG_Logo_color-BRWIWI.jpeg https://medicaex.com/businesswire/the-route-du-rhum-is-under-way-alberto-bonas-big-dream-on-class40-ibsa-has-started/ 2022-11-10T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/IBSA_RdR_StartDay24-pIedPa.jpeg https://medicaex.com/businesswire/her2dx-recognized-by-time-as-one-of-the-best-inventions-of-2022-2/ 2022-11-10T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Her2dx_logo_Color-aGCNpr.jpeg https://medicaex.com/businesswire/astrazeneca-evusheld-named-on-times-list-of-the-best-inventions-of-2022-2/ 2022-11-10T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-EuPP7K.jpeg https://medicaex.com/businesswire/timelymd-named-top-workplace-in-north-texas-2/ 2022-11-10T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/TimelyMD-Logo-Horz-ooGhzo.jpeg https://medicaex.com/businesswire/her2dx-recognized-by-time-as-one-of-the-best-inventions-of-2022/ 2022-11-10T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Her2dx_logo_Color-ovn9YX.jpeg https://medicaex.com/businesswire/astrazeneca-evusheld-named-on-times-list-of-the-best-inventions-of-2022/ 2022-11-10T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-MeUlNj.jpeg https://medicaex.com/businesswire/timelymd-named-top-workplace-in-north-texas/ 2022-11-10T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/TimelyMD-Logo-Horz-sXHQ4R.jpeg https://medicaex.com/businesswire/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel-2/ 2022-11-10T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Website_Featured_JPG-IQVIA_Logo_-_Tricolor-NJrotc.jpeg https://medicaex.com/businesswire/the-gut-microbiomes-supersized-role-in-shaping-molecules-in-our-blood/ 2022-11-10T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gibbons-Diener-Nature_Metabolism-11-2022_Shortened-vyL332.jpeg https://medicaex.com/businesswire/us-government-grants-modmed-a-patent/ 2022-11-10T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Patent_PR_Media-Hdgpj9.jpeg https://medicaex.com/businesswire/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel/ 2022-11-10T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Website_Featured_JPG-IQVIA_Logo_-_Tricolor-B6us8e.jpeg https://medicaex.com/businesswire/london-school-of-hygiene-tropical-medicine-selects-zenoss-to-ensure-availability-of-it-services/ 2022-11-10T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Zenoss_logo_tag_PMS021_28229-q0MvKU.jpeg https://medicaex.com/businesswire/dc-child-and-family-services-agency-to-use-artificial-intelligence-in-support-of-child-welfare-programs/ 2022-11-10T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/lyssn-rgb-full-color-5tVdWU.jpeg https://medicaex.com/businesswire/medikine-presents-preliminary-results-of-a-single-dose-phase-1-healthy-subject-study-of-mdk-703-a-peptide-based-mimetic-of-interleukin-7-il-7-2/ 2022-11-10T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/MedikineLogo_03-02-2022_401000px-kZbIb0.jpeg https://medicaex.com/businesswire/echosens-fibroscan-improves-quality-of-care-at-americas-veterans-health-administration-facilities-provides-early-detection-and-monitoring-of-liver-disease-3/ 2022-11-10T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_echosens_gradient-lMgWcu.jpeg https://medicaex.com/businesswire/tivic-health-announces-manufacturing-partnership-with-microart-2/ 2022-11-10T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-bdDSRU.jpeg https://medicaex.com/businesswire/rallybio-announces-proposed-public-offering/ 2022-11-10T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Press_Release_Logo-g1U8ok.jpeg https://medicaex.com/businesswire/echosens-fibroscan-improves-quality-of-care-at-americas-veterans-health-administration-facilities-provides-early-detection-and-monitoring-of-liver-disease-2/ 2022-11-10T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_echosens_gradient-8NbSoA.jpeg https://medicaex.com/businesswire/gozio-health-and-artera-launch-deeper-partnership-and-integrations-to-create-more-seamless-digital-experience-for-patients/ 2022-11-10T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/GozioHealth_2048x1354_transparent-xCrKOO.jpeg https://medicaex.com/businesswire/great-speech-awarded-contract-with-healthcare-highways-provides-access-to-virtual-speech-therapy-for-members-of-leading-health-plan-2/ 2022-11-10T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/GSlogo-virtual-sS4Iwh.jpeg https://medicaex.com/businesswire/webmd-announces-the-recipients-of-the-2022-webmd-choice-awards-2/ 2022-11-10T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Choice-Awards-Elite-Social-Ad-iZsX7s.jpeg https://medicaex.com/businesswire/the-villages-health-showcases-kaid-health-technology-in-journal-of-medical-practice-management-case-study/ 2022-11-10T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/KAIDHealth_logo_4-xcJzfy.jpeg https://medicaex.com/businesswire/vicarious-surgical-system-named-to-times-list-of-the-best-inventions-of-2022/ 2022-11-10T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-TxJmyE.jpeg https://medicaex.com/businesswire/tivic-health-announces-manufacturing-partnership-with-microart/ 2022-11-10T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-8ECxyd.jpeg https://medicaex.com/businesswire/case-study-documents-the-value-of-foot-levelers-custom-flexible-orthotics-to-improve-work-performance-and-overall-health-of-firefighters-2/ 2022-11-10T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/11.2.22_Foot_Levelers_Video-G9kv5N.jpeg https://medicaex.com/businesswire/echosens-fibroscan-improves-quality-of-care-at-americas-veterans-health-administration-facilities-provides-early-detection-and-monitoring-of-liver-disease/ 2022-11-10T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_echosens_gradient-CA3d6W.jpeg https://medicaex.com/businesswire/aural-analytics-awarded-key-iso-certifications-for-its-clinical-grade-speech-analytics/ 2022-11-10T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/aural-logo-vFINAL-pos-CROP_28129-ATfx2a.jpeg https://medicaex.com/businesswire/case-study-documents-the-value-of-foot-levelers-custom-flexible-orthotics-to-improve-work-performance-and-overall-health-of-firefighters/ 2022-11-10T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/11.2.22_Foot_Levelers_Video-axYbKF.jpeg https://medicaex.com/businesswire/global-opioid-use-disorder-market-report-to-2031-featuring-alkermes-astrazeneca-biodelivery-sciences-international-and-camurus-among-others-researchandmarkets-com/ 2022-11-10T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ztrq04.jpeg https://medicaex.com/businesswire/medikine-presents-preliminary-results-of-a-single-dose-phase-1-healthy-subject-study-of-mdk-703-a-peptide-based-mimetic-of-interleukin-7-il-7/ 2022-11-10T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/MedikineLogo_03-02-2022_401000px-hamca3.jpeg https://medicaex.com/businesswire/world-leading-pharmaceuticals-manufacturer-chooses-dtex-intercept-to-protect-research-secure-patents-and-prevent-data-loss/ 2022-11-10T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_NEW_DTEX_Logo_070721_Positive_RGB_28129-pL2ISy.jpeg https://medicaex.com/businesswire/great-speech-awarded-contract-with-healthcare-highways-provides-access-to-virtual-speech-therapy-for-members-of-leading-health-plan/ 2022-11-10T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/GSlogo-virtual-RU4tfy.jpeg https://medicaex.com/businesswire/webmd-announces-the-recipients-of-the-2022-webmd-choice-awards/ 2022-11-10T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Choice-Awards-Elite-Social-Ad-pvQDSM.jpeg https://medicaex.com/businesswire/collective-health-surpasses-100-ecosystem-partners-and-processes-23-6-million-claims-to-date/ 2022-11-10T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/CH_brand_logo_1-vN3sIf.jpeg https://medicaex.com/businesswire/repertoire-immune-medicines-presents-new-data-from-its-decode-platform-identifying-highly-prevalent-immunotherapeutic-targets-in-hpv-positive-cancers-unlocking-pathways-for-potential-t/ 2022-11-10T14:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Repoirtoire_RBG_28229-qnWJwS.jpeg https://medicaex.com/businesswire/klick-health-builds-out-global-leadership-team-and-offices-2/ 2022-11-10T14:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Klick_Logo_Final_Vertical_RGB_F_10072019-Qfe7I6.jpeg https://medicaex.com/businesswire/aulos-bioscience-presents-initial-data-from-first-in-human-phase-1-2-clinical-trial-of-computationally-designed-antibody-au-007-at-37th-society-for-immunotherapy-of-cancer-sitc-annual-meeting-2/ 2022-11-10T14:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Aulos_Logo_2022FEB22-RuR4W0.jpeg https://medicaex.com/businesswire/xencor-presents-early-clinical-data-from-combination-study-of-vudalimab-and-new-data-from-multiple-preclinical-stage-xmab-programs-at-the-sitc-annual-meeting-2/ 2022-11-10T14:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Xencor_logo_BW-Bf5wKv.jpeg https://medicaex.com/businesswire/bicycle-therapeutics-to-present-five-posters-highlighting-preclinical-data-from-its-bicycle-tumor-targeted-immune-cell-agonist-bicycle-tica-programs-at-the-sitc-37th-annual-meeting-2/ 2022-11-10T14:12:16+00:00 https://medicaex.com/businesswire/biodesix-presents-new-data-from-the-insight-study-at-the-2022-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting/ 2022-11-10T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biodesix_Logo-L28fFj.jpeg https://medicaex.com/businesswire/brighton-park-capital-completes-second-fundraise-with-1-8-billion-of-commitments/ 2022-11-10T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/bpc-logo-9d57ba2bdac50817e44905eef0ef5e80-6p3Cd6.jpeg https://medicaex.com/businesswire/picnichealth-announces-engagement-with-bristol-myers-squibb-to-leverage-real-world-evidence-to-study-symptomatic-obstructive-hypertrophic-cardiomyopathy-patients/ 2022-11-10T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/PicnicHealth_Vertical_Color_Logo-3mjl2Z.jpeg https://medicaex.com/businesswire/komodo-healths-real-world-evidence-and-technology-platform-powers-two-real-world-analyses-in-primary-biliary-cholangitis-for-intercept-pharmaceuticals/ 2022-11-10T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/kh-logo-full_28229-ICEZZu.jpeg https://medicaex.com/businesswire/whoop-unite-and-ashley-addiction-treatment-partner-to-break-new-ground-in-research-and-patient-care-2/ 2022-11-10T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/WHOOP_Logo_R_Black_28129_28129-mazEMN.jpeg https://medicaex.com/businesswire/global-point-of-care-diagnostics-market-2022-developments-including-ai-integration-drive-sector-forward-researchandmarkets-com-2/ 2022-11-10T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-tUoHI6.jpeg https://medicaex.com/businesswire/warren-general-hospital-selects-meditech-expanse-maintains-independence/ 2022-11-10T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/MEDITECH_Logo_28129-7ijADo.jpeg https://medicaex.com/businesswire/former-cvs-health-chief-strategy-officer-josh-flum-joins-lrvhealth-as-managing-partner/ 2022-11-10T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/LRV-Health-Logo-Stacked-CMYK-2-Color-mt4TEH.jpeg https://medicaex.com/businesswire/lucid-diagnostics-to-participate-in-canaccord-genuitys-medtech-diagnostics-and-digital-health-services-forum/ 2022-11-10T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/LUCD_Logo-cKIrxg.jpeg https://medicaex.com/businesswire/whoop-unite-and-ashley-addiction-treatment-partner-to-break-new-ground-in-research-and-patient-care/ 2022-11-10T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/WHOOP_Logo_R_Black_28129_28129-jqmwZY.jpeg https://medicaex.com/businesswire/innovative-health-diagnostics-adds-new-leadership-team-member/ 2022-11-10T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-bZjzp2.jpeg https://medicaex.com/businesswire/global-point-of-care-diagnostics-market-2022-developments-including-ai-integration-drive-sector-forward-researchandmarkets-com/ 2022-11-10T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-OOgZKI.jpeg https://medicaex.com/businesswire/aulos-bioscience-presents-initial-data-from-first-in-human-phase-1-2-clinical-trial-of-computationally-designed-antibody-au-007-at-37th-society-for-immunotherapy-of-cancer-sitc-annual-meeting/ 2022-11-10T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Aulos_Logo_2022FEB22-DDRG5Q.jpeg https://medicaex.com/businesswire/xencor-presents-early-clinical-data-from-combination-study-of-vudalimab-and-new-data-from-multiple-preclinical-stage-xmab-programs-at-the-sitc-annual-meeting/ 2022-11-10T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Xencor_logo_BW-7Xvlqo.jpeg https://medicaex.com/businesswire/research-revolution-conference-powered-by-florence-healthcare-tackles-slowdown-in-drug-development-due-to-trial-site-stress/ 2022-11-10T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/FHC_Logo_2800229-zVVOv0.jpeg https://medicaex.com/businesswire/bicycle-therapeutics-to-present-five-posters-highlighting-preclinical-data-from-its-bicycle-tumor-targeted-immune-cell-agonist-bicycle-tica-programs-at-the-sitc-37th-annual-meeting/ 2022-11-10T14:12:06+00:00 https://medicaex.com/businesswire/klick-health-builds-out-global-leadership-team-and-offices/ 2022-11-10T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Klick_Logo_Final_Vertical_RGB_F_10072019-40462S.jpeg https://medicaex.com/businesswire/michael-gorton-teladoc-founder-recuro-ceo-co-authors-book-with-jay-sanders-md-father-of-telemedicine-digital-medical-home-telemedicine-ignites-creation-of-precision-health/ 2022-11-10T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Book-DigitalMedicalHome-PRHero-LAshgU.jpeg https://medicaex.com/businesswire/current-health-makes-its-end-to-end-care-at-home-platform-available-in-the-epic-app-market/ 2022-11-10T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Current_Health_Logo-4nQtX5.jpeg https://medicaex.com/businesswire/inscopix-launches-nvisiontm-system-for-synchronized-acquisition-of-behavioral-movies-with-in-vivo-miniscope-data-2/ 2022-11-10T13:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inscopix_Logo_JPG-tI69P9.jpeg https://medicaex.com/businesswire/anebulo-pharmaceuticals-reports-first-quarter-fiscal-year-2023-financial-results-and-recent-updates-2/ 2022-11-10T13:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANEB_Logo_white-3WXnQt.jpeg https://medicaex.com/businesswire/abcellera-presents-new-data-on-further-development-and-characterization-of-t-cell-engager-platform-at-sitc-2022-2/ 2022-11-10T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-fGa2HG.jpeg https://medicaex.com/businesswire/aimmune-therapeutics-to-present-positive-results-from-phase-3-poseidon-study-of-palforzia-peanut-arachis-hypogaea-allergen-powder-dnfp-in-peanut-allergic-children-aged-1-to-3-years-2/ 2022-11-10T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/aimmune_logo-WGlLe7.jpeg https://medicaex.com/businesswire/vbi-vaccines-reports-third-quarter-2022-financial-results-and-provides-corporate-update-2/ 2022-11-10T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/VBI_Vaccines_Logo_Horiz_RGB-J15bkz.jpeg https://medicaex.com/businesswire/evercore-isi-and-digital-therapeutics-alliance-to-host-dtx-leaders-at-hlth-2022/ 2022-11-10T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Evercore_Logo-5z0zPR.jpeg https://medicaex.com/businesswire/binx-health-announces-strategic-supply-agreement-with-afaxys-to-expand-sexual-health-test-access-to-thousands-of-clinics-nationally-3/ 2022-11-10T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_black-1-nNaVEw.jpeg https://medicaex.com/businesswire/pear-therapeutics-to-participate-in-the-btig-digital-health-forum/ 2022-11-10T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-BwHSjh.jpeg https://medicaex.com/businesswire/inscopix-launches-nvisiontm-system-for-synchronized-acquisition-of-behavioral-movies-with-in-vivo-miniscope-data/ 2022-11-10T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inscopix_Logo_JPG-y3ObG9.jpeg https://medicaex.com/businesswire/sprinter-health-and-firefly-health-partner-to-bring-a-new-model-of-hybrid-care-to-patients-delivered-in-the-home-and-powered-by-technology-for-scale/ 2022-11-10T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/sprinterhealt_logo_primary-6MM8TK.jpeg https://medicaex.com/businesswire/new-study-finds-85-of-aneurysms-identified-by-viz-aneurysm-had-not-been-referred-for-neurovascular-review/ 2022-11-10T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/VIZ_Anuerysm_Screen_Shots-KxfwkX.jpeg https://medicaex.com/businesswire/acacia-research-reports-third-quarter-2022-financial-results/ 2022-11-10T13:12:10+00:00 https://medicaex.com/businesswire/contraline-announces-first-patients-successfully-implanted-in-male-contraceptive-study/ 2022-11-10T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/DSC_0230_28129-ks6PvR.jpeg https://medicaex.com/businesswire/establishment-labs-announces-japanese-regulatory-approval-and-reimbursement-for-motiva-implants-and-the-motiva-flora-tissue-expander-for-use-in-post-mastectomy-reconstruction-2/ 2022-11-10T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/ESTA_logo_color-E5Orrm.jpeg https://medicaex.com/businesswire/binx-health-announces-strategic-supply-agreement-with-afaxys-to-expand-sexual-health-test-access-to-thousands-of-clinics-nationally-2/ 2022-11-10T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_black-1-rr7Guo.jpeg https://medicaex.com/businesswire/binx-health-announces-strategic-supply-agreement-with-afaxys-to-expand-sexual-health-test-access-to-thousands-of-clinics-nationally/ 2022-11-10T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_black-1-CHbQb8.jpeg https://medicaex.com/businesswire/urogen-pharma-reports-third-quarter-2022-financial-results-and-recent-corporate-developments/ 2022-11-10T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/UroGen_logo2_28R29-O68KwI.jpeg https://medicaex.com/businesswire/abcellera-presents-new-data-on-further-development-and-characterization-of-t-cell-engager-platform-at-sitc-2022/ 2022-11-10T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-6Y6iak.jpeg https://medicaex.com/businesswire/aimmune-therapeutics-to-present-positive-results-from-phase-3-poseidon-study-of-palforzia-peanut-arachis-hypogaea-allergen-powder-dnfp-in-peanut-allergic-children-aged-1-to-3-years/ 2022-11-10T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/aimmune_logo-oHEt2O.jpeg https://medicaex.com/businesswire/vbi-vaccines-reports-third-quarter-2022-financial-results-and-provides-corporate-update/ 2022-11-10T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/VBI_Vaccines_Logo_Horiz_RGB-2bCMhk.jpeg https://medicaex.com/businesswire/anebulo-pharmaceuticals-reports-first-quarter-fiscal-year-2023-financial-results-and-recent-updates/ 2022-11-10T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANEB_Logo_white-oj2kmX.jpeg https://medicaex.com/businesswire/onconano-medicine-announces-pre-clinical-data-for-dual-activating-sting-agonist-at-the-society-for-immunotherapy-of-cancer-sitc-annual-meeting/ 2022-11-10T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Onconano_Horizontal_Logo_full_color-1DXYEt.jpeg https://medicaex.com/businesswire/establishment-labs-announces-japanese-regulatory-approval-and-reimbursement-for-motiva-implants-and-the-motiva-flora-tissue-expander-for-use-in-post-mastectomy-reconstruction/ 2022-11-10T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/ESTA_logo_color-LM4W0J.jpeg https://medicaex.com/businesswire/seagen-names-david-r-epstein-as-chief-executive-officer-and-director-2/ 2022-11-10T12:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/11/Seagen_Logo_RGB-VWwcU1.jpeg https://medicaex.com/businesswire/orthofix-medical-announces-participation-in-upcoming-stifel-healthcare-conference-2/ 2022-11-10T12:12:21+00:00 https://medicaex.com/businesswire/seagen-appoints-sandra-m-swain-m-d-to-board-of-directors-2/ 2022-11-10T12:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/Seagen_Logo_RGB-Vmnql7.jpeg https://medicaex.com/businesswire/silence-therapeutics-reports-third-quarter-2022-results-2/ 2022-11-10T12:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/Silence-Logo-FINAL-rgb-omKnlB.jpeg https://medicaex.com/businesswire/aldeyra-therapeutics-reports-third-quarter-2022-financial-results-and-recent-corporate-highlights-2/ 2022-11-10T12:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/ALDX_logo_JPEG-Mk6xHF.jpeg https://medicaex.com/businesswire/delphinus-medical-ships-softvue-breast-imaging-system-to-east-alabama-medical-center-2/ 2022-11-10T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Delphinus_Logo_600px-5JVuZR.jpeg https://medicaex.com/businesswire/beigene-announces-brazil-approvals-for-brukinsa-as-a-treatment-for-rare-blood-cancers-2/ 2022-11-10T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-jwtogB.jpeg https://medicaex.com/businesswire/us-tech-startup-subjectwell-secures-35-million-in-investment-focuses-growth-in-south-african-operations-2/ 2022-11-10T12:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/subjectwell-logo-2OVdtp.jpeg https://medicaex.com/businesswire/908-devices-records-strong-momentum-in-life-sciences-sector-2/ 2022-11-10T12:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/908Devices_Logo_Primary-ZC12UF.jpeg https://medicaex.com/businesswire/apyx-medical-corporation-reports-third-quarter-2022-financial-results-and-updates-full-year-2022-financial-outlook-2/ 2022-11-10T12:12:14+00:00 https://medicaex.com/businesswire/orthofix-medical-announces-participation-in-upcoming-stifel-healthcare-conference/ 2022-11-10T12:12:14+00:00 https://medicaex.com/businesswire/908-devices-records-strong-momentum-in-life-sciences-sector/ 2022-11-10T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/908Devices_Logo_Primary-9hVhMZ.jpeg https://medicaex.com/businesswire/delphinus-medical-ships-softvue-breast-imaging-system-to-east-alabama-medical-center/ 2022-11-10T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Delphinus_Logo_600px-NO5ST6.jpeg https://medicaex.com/businesswire/beigene-announces-brazil-approvals-for-brukinsa-as-a-treatment-for-rare-blood-cancers/ 2022-11-10T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-u9jToy.jpeg https://medicaex.com/businesswire/apyx-medical-corporation-reports-third-quarter-2022-financial-results-and-updates-full-year-2022-financial-outlook/ 2022-11-10T12:12:12+00:00 https://medicaex.com/businesswire/seagen-names-david-r-epstein-as-chief-executive-officer-and-director/ 2022-11-10T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Seagen_Logo_RGB-QNgPqo.jpeg https://medicaex.com/businesswire/aldeyra-therapeutics-reports-third-quarter-2022-financial-results-and-recent-corporate-highlights/ 2022-11-10T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ALDX_logo_JPEG-hSydYN.jpeg https://medicaex.com/businesswire/us-tech-startup-subjectwell-secures-35-million-in-investment-focuses-growth-in-south-african-operations/ 2022-11-10T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/subjectwell-logo-7GMXYC.jpeg https://medicaex.com/businesswire/silence-therapeutics-reports-third-quarter-2022-results/ 2022-11-10T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Silence-Logo-FINAL-rgb-Y7tgQE.jpeg https://medicaex.com/businesswire/seagen-appoints-sandra-m-swain-m-d-to-board-of-directors/ 2022-11-10T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Seagen_Logo_RGB-NkumeX.jpeg https://medicaex.com/businesswire/nanostring-to-webcast-presentations-from-two-upcoming-healthcare-conferences-2/ 2022-11-10T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/4891105_NSTG_logo_for_Yahoo-gfKO3O.jpeg https://medicaex.com/businesswire/new-inventprise-pneumococcal-vaccine-enters-phase-1-2-clinical-evaluation-2/ 2022-11-10T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inventprise_Logo-01_28629-crlAMB.jpeg https://medicaex.com/businesswire/atom-bioscience-to-present-final-data-from-its-positive-phase-2a-clinical-trial-in-chronic-gout-at-american-college-of-rheumatology-annual-meeting-nov-10-14-in-philadelphia-pa-2/ 2022-11-10T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Atom_Bioscience_Logo_28129-IW2RyS.jpeg https://medicaex.com/businesswire/babylon-reports-another-strong-quarter-ahead-of-consensus-estimates-with-revenue-growth-of-3-9x-and-45-ppts-adjusted-ebitda-margin-improvement-2/ 2022-11-10T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/BYLN_Logo_FC_Landscape_377x177_RGB-PR-E8zlLb.jpeg https://medicaex.com/businesswire/nanostring-to-webcast-presentations-from-two-upcoming-healthcare-conferences/ 2022-11-10T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/4891105_NSTG_logo_for_Yahoo-OIrhDe.jpeg https://medicaex.com/businesswire/outlook-on-the-medical-displays-global-market-to-2027-oled-segment-to-record-a-5-7-cagr-researchandmarkets-com/ 2022-11-10T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oeefIH.jpeg https://medicaex.com/businesswire/pharmacovigilance-global-market-report-2022-rising-cases-of-adverse-drug-reactions-fueling-growth-researchandmarkets-com/ 2022-11-10T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6JQ8Ow.jpeg https://medicaex.com/businesswire/new-inventprise-pneumococcal-vaccine-enters-phase-1-2-clinical-evaluation/ 2022-11-10T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inventprise_Logo-01_28629-nY0D7e.jpeg https://medicaex.com/businesswire/atom-bioscience-to-present-final-data-from-its-positive-phase-2a-clinical-trial-in-chronic-gout-at-american-college-of-rheumatology-annual-meeting-nov-10-14-in-philadelphia-pa/ 2022-11-10T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Atom_Bioscience_Logo_28129-4ASDq8.jpeg https://medicaex.com/businesswire/outlook-on-the-sodium-nitrate-global-market-to-2027-pharmaceuticals-segment-to-record-11-1-cagr-researchandmarkets-com/ 2022-11-10T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bgZUox.jpeg https://medicaex.com/businesswire/babylon-reports-another-strong-quarter-ahead-of-consensus-estimates-with-revenue-growth-of-3-9x-and-45-ppts-adjusted-ebitda-margin-improvement/ 2022-11-10T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/BYLN_Logo_FC_Landscape_377x177_RGB-PR-0c7rEz.jpeg https://medicaex.com/businesswire/novo-nordisks-smart-connected-pens-are-now-compatible-with-abbotts-freestyle-librelink-app-2/ 2022-11-10T08:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/nn_black-QrLwct.jpeg https://medicaex.com/businesswire/novo-nordisks-smart-connected-pens-are-now-compatible-with-abbotts-freestyle-librelink-app/ 2022-11-10T08:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/nn_black-YP9xWT.jpeg https://medicaex.com/businesswire/onwards-research-partner-neurorestore-publishes-groundbreaking-paper-identifying-neurons-that-restore-walking-after-paralysis-3/ 2022-11-10T07:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-MduIoo.jpeg https://medicaex.com/businesswire/almiralls-nine-month-2022-results-2/ 2022-11-10T07:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/ALM_AW_LOGO_Tagline_MV_Positive_RGB_28129-6ZlXPa.jpeg https://medicaex.com/businesswire/onwards-research-partner-neurorestore-publishes-groundbreaking-paper-identifying-neurons-that-restore-walking-after-paralysis-2/ 2022-11-10T07:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-i6IFR6.jpeg https://medicaex.com/businesswire/onwards-research-partner-neurorestore-publishes-groundbreaking-paper-identifying-neurons-that-restore-walking-after-paralysis/ 2022-11-10T07:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-q3zba3.jpeg https://medicaex.com/businesswire/almiralls-nine-month-2022-results/ 2022-11-10T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ALM_AW_LOGO_Tagline_MV_Positive_RGB_28129-LSAgEJ.jpeg https://medicaex.com/businesswire/kpj-healthcare-partners-with-pine-labs-to-offer-patients-instalment-payment-plans/ 2022-11-10T02:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/pinelabs-SGRgdo.jpeg https://medicaex.com/businesswire/bioceres-crop-solutions-reports-fiscal-first-quarter-2023-financial-and-operational-results/ 2022-11-10T00:12:13+00:00 https://medicaex.com/businesswire/ge-announces-pricing-of-offerings-of-8-25-billion-senior-notes-issued-by-ge-healthcare/ 2022-11-09T23:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/GEMongram28Blue-PMS745529300dpi-AoRl7H.jpeg https://medicaex.com/businesswire/sqz-biotechnologies-reports-third-quarter-2022-financial-results-and-recent-portfolio-updates-2/ 2022-11-09T22:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/SQZ_Logo-Medium-7XWpBs.jpeg https://medicaex.com/businesswire/phibro-animal-health-corporation-reports-first-quarter-results-revised-guidance-2/ 2022-11-09T22:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/JPG_Phibro_AnimalHealthCorporation_Color_RGB_edited-Ag6VAO.jpeg https://medicaex.com/businesswire/diamedica-therapeutics-provides-a-business-update-and-announces-third-quarter-2022-financial-results-2/ 2022-11-09T22:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/DiaMedica-Logo-white-background-TKt8eZ.jpeg https://medicaex.com/businesswire/maia-biotechnology-reports-third-quarter-2022-financial-results-and-provides-corporate-update-2/ 2022-11-09T22:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/MAIA_logo-c8fZKB.jpeg https://medicaex.com/businesswire/idex-corporation-declare-regular-quarterly-cash-dividend/ 2022-11-09T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/IDEX_Tagline_Blue_Stacked_Square_28129-TgBEoc.jpeg https://medicaex.com/businesswire/rockley-photonics-reports-third-quarter-of-fiscal-2022-financial-results-3/ 2022-11-09T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockley-logo-500-x-500-EvlrZ9.jpeg https://medicaex.com/businesswire/rockley-photonics-reports-third-quarter-of-fiscal-2022-financial-results-2/ 2022-11-09T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockley-logo-500-x-500-4EzIjn.jpeg https://medicaex.com/businesswire/rockley-photonics-reports-third-quarter-of-fiscal-2022-financial-results/ 2022-11-09T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockley-logo-500-x-500-XlBwpO.jpeg https://medicaex.com/businesswire/maia-biotechnology-reports-third-quarter-2022-financial-results-and-provides-corporate-update/ 2022-11-09T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/MAIA_logo-mjfnGH.jpeg https://medicaex.com/businesswire/phibro-animal-health-corporation-reports-first-quarter-results-revised-guidance/ 2022-11-09T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/JPG_Phibro_AnimalHealthCorporation_Color_RGB_edited-n4PlJ7.jpeg https://medicaex.com/businesswire/diamedica-therapeutics-provides-a-business-update-and-announces-third-quarter-2022-financial-results/ 2022-11-09T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/DiaMedica-Logo-white-background-trXo7Q.jpeg https://medicaex.com/businesswire/sqz-biotechnologies-reports-third-quarter-2022-financial-results-and-recent-portfolio-updates/ 2022-11-09T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/SQZ_Logo-Medium-kIXJHq.jpeg https://medicaex.com/businesswire/masimo-to-present-in-stifel-2022-healthcare-conference-2/ 2022-11-09T21:12:16+00:00 https://medicaex.com/businesswire/outset-medical-to-present-at-upcoming-investor-conferences-3/ 2022-11-09T21:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Outset-ID-OrangeGrey-XvE9MC.jpeg https://medicaex.com/businesswire/cardiovascular-systems-inc-to-participate-in-two-november-healthcare-conferences-2/ 2022-11-09T21:12:16+00:00 https://medicaex.com/businesswire/arcus-biosciences-announces-new-employment-inducement-grants-2/ 2022-11-09T21:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/ARCUS_Logo_RGB_1920x1080-JzpfUM.jpeg https://medicaex.com/businesswire/savara-to-participate-in-three-upcoming-investor-conferences-2/ 2022-11-09T21:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Savara_Logo_2800229-4KIYSf.jpeg https://medicaex.com/businesswire/outset-medical-to-present-at-upcoming-investor-conferences-2/ 2022-11-09T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Outset-ID-OrangeGrey-GqIDDg.jpeg https://medicaex.com/businesswire/senseonics-to-present-at-the-stifel-2022-healthcare-conference-2/ 2022-11-09T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/SENS_logo-X0v7nl.jpeg https://medicaex.com/businesswire/cue-health-reports-third-quarter-2022-results-2/ 2022-11-09T21:12:12+00:00 https://medicaex.com/businesswire/masimo-to-present-in-stifel-2022-healthcare-conference/ 2022-11-09T21:12:10+00:00 https://medicaex.com/businesswire/outset-medical-to-present-at-upcoming-investor-conferences/ 2022-11-09T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Outset-ID-OrangeGrey-Pwi0Fw.jpeg https://medicaex.com/businesswire/cardiovascular-systems-inc-to-participate-in-two-november-healthcare-conferences/ 2022-11-09T21:12:10+00:00 https://medicaex.com/businesswire/senseonics-to-present-at-the-stifel-2022-healthcare-conference/ 2022-11-09T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/SENS_logo-59gR0u.jpeg https://medicaex.com/businesswire/koru-medical-systems-announces-2022-third-quarter-financial-results-2/ 2022-11-09T21:12:10+00:00 https://medicaex.com/businesswire/koru-medical-systems-announces-2022-third-quarter-financial-results/ 2022-11-09T21:12:08+00:00 https://medicaex.com/businesswire/cue-health-reports-third-quarter-2022-results/ 2022-11-09T21:12:08+00:00 https://medicaex.com/businesswire/arcus-biosciences-announces-new-employment-inducement-grants/ 2022-11-09T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ARCUS_Logo_RGB_1920x1080-6MO4a9.jpeg https://medicaex.com/businesswire/savara-to-participate-in-three-upcoming-investor-conferences/ 2022-11-09T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Savara_Logo_2800229-eo1uGs.jpeg https://medicaex.com/businesswire/graphite-bio-reports-recent-business-progress-and-third-quarter-2022-financial-results/ 2022-11-09T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Graphite_Bio_Primary_Logo_RGB_M01-eXED0G.jpeg https://medicaex.com/businesswire/novabay-pharmaceuticals-to-hold-third-quarter-2022-conference-call-on-november-14/ 2022-11-09T21:12:05+00:00 https://medicaex.com/businesswire/innoviva-reports-third-quarter-2022-financial-results-and-highlights-recent-company-progress/ 2022-11-09T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/INVA_Logo-KJHUaT.jpeg https://medicaex.com/businesswire/ontrak-announces-2022-third-quarter-financial-results/ 2022-11-09T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/OTRK_Logo_2022-02-03-tUODtE.jpeg https://medicaex.com/businesswire/mdi-acquires-two-medical-tubing-and-extrusion-companies-from-schauenburg-hose-technology/ 2022-11-09T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/MDI_High_Res-GxeK4B.jpeg https://medicaex.com/businesswire/johannesburg-gets-ready-for-healthcare-innovation-summit-africa-2022-4/ 2022-11-09T18:12:14+00:00 https://medicaex.com/businesswire/forcura-achieves-hitrust-risk-based-2-year-certification-to-manage-risk-improve-security-posture-and-meet-compliance-requirements/ 2022-11-09T18:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Forcura-fllwz9.jpeg https://medicaex.com/businesswire/johannesburg-gets-ready-for-healthcare-innovation-summit-africa-2022-3/ 2022-11-09T18:12:11+00:00 https://medicaex.com/businesswire/johannesburg-gets-ready-for-healthcare-innovation-summit-africa-2022-2/ 2022-11-09T18:12:09+00:00 https://medicaex.com/businesswire/johannesburg-gets-ready-for-healthcare-innovation-summit-africa-2022/ 2022-11-09T18:12:05+00:00 https://medicaex.com/businesswire/immunome-presents-preclinical-data-on-novel-anti-epn1-antibody-imm20059-at-the-society-for-immunotherapy-of-cancers-sitc-37th-annual-meeting-2/ 2022-11-09T17:12:13+00:00 https://medicaex.com/businesswire/global-hand-held-chemical-and-metal-detector-market-report-2022-2026-2031-featuring-osi-systems-teledyne-technologies-smiths-group-thermo-fisher-scientific-agilent-technologies-resea-2/ 2022-11-09T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-GY3tmq.jpeg https://medicaex.com/businesswire/physiq-launches-the-intrepid-partner-program-5/ 2022-11-09T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-WnUNHN.jpeg https://medicaex.com/businesswire/physiq-launches-the-intrepid-partner-program-4/ 2022-11-09T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-xHWWJR.jpeg https://medicaex.com/businesswire/fathom-secures-46m-series-b-financing/ 2022-11-09T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-fathom-IBrmzg.jpeg https://medicaex.com/businesswire/the-worldwide-sports-mouthguard-industry-is-expected-to-reach-5-7-billion-by-2027-researchandmarkets-com-2/ 2022-11-09T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-VhwXoJ.jpeg https://medicaex.com/businesswire/physiq-launches-the-intrepid-partner-program-3/ 2022-11-09T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-K45HHl.jpeg https://medicaex.com/businesswire/the-worldwide-sports-mouthguard-industry-is-expected-to-reach-5-7-billion-by-2027-researchandmarkets-com/ 2022-11-09T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Echb10.jpeg https://medicaex.com/businesswire/immunome-presents-preclinical-data-on-novel-anti-epn1-antibody-imm20059-at-the-society-for-immunotherapy-of-cancers-sitc-37th-annual-meeting/ 2022-11-09T17:12:05+00:00 https://medicaex.com/businesswire/ascensus-acquires-independent-distributor/ 2022-11-09T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/We_believe_in_making_a_difference_in_someones_life-4db6QU.jpeg https://medicaex.com/businesswire/global-hand-held-chemical-and-metal-detector-market-report-2022-2026-2031-featuring-osi-systems-teledyne-technologies-smiths-group-thermo-fisher-scientific-agilent-technologies-resea/ 2022-11-09T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-gfk1X9.jpeg https://medicaex.com/businesswire/insights-on-the-hiv-clinical-trials-global-market-to-2027-advancements-in-hiv-clinical-trials-solutions-significant-rise-in-the-treatment-diagnosis-rate-of-hiv-infections-present-opportu/ 2022-11-09T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-rUHbif.jpeg https://medicaex.com/businesswire/physiq-launches-the-intrepid-partner-program-2/ 2022-11-09T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-sBAseT.jpeg https://medicaex.com/businesswire/physiq-launches-the-intrepid-partner-program/ 2022-11-09T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-vanxXR.jpeg https://medicaex.com/businesswire/biometric-sensors-global-market-report-2022-capacitive-optical-thermal-ultrasound-electric-field-voice-finger-hand-facial-iris-vein-long-term-forecasts-to-2026-2031-researchandmar-3/ 2022-11-09T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Z0d81f.jpeg https://medicaex.com/businesswire/cell-free-protein-expression-global-market-report-2022-rising-research-and-development-activities-by-market-players-drives-sector-forward-researchandmarkets-com-2/ 2022-11-09T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-eHPcDl.jpeg https://medicaex.com/businesswire/global-precision-medicine-market-report-2022-collaborations-partnerships-between-major-players-fuel-sector-researchandmarkets-com-2/ 2022-11-09T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6RWK3L.jpeg https://medicaex.com/businesswire/guided-therapeutics-provides-update-of-significant-progress-in-chinese-clinical-study-for-marketing-approval-of-the-luviva-advanced-cervical-scan-2/ 2022-11-09T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/GTI_logo_2021-kSDgFX.jpeg https://medicaex.com/businesswire/worldwide-bioremediation-technology-and-services-industry-to-2028-featuring-drylet-probiosphere-regenesis-remediation-solutions-and-xylem-among-others-researchandmarkets-com/ 2022-11-09T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-z4tDBK.jpeg https://medicaex.com/businesswire/biometric-sensors-global-market-report-2022-capacitive-optical-thermal-ultrasound-electric-field-voice-finger-hand-facial-iris-vein-long-term-forecasts-to-2026-2031-researchandmar-2/ 2022-11-09T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-v3kSSZ.jpeg https://medicaex.com/businesswire/biometric-sensors-global-market-report-2022-capacitive-optical-thermal-ultrasound-electric-field-voice-finger-hand-facial-iris-vein-long-term-forecasts-to-2026-2031-researchandmar/ 2022-11-09T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-p51b1W.jpeg https://medicaex.com/businesswire/guided-therapeutics-provides-update-of-significant-progress-in-chinese-clinical-study-for-marketing-approval-of-the-luviva-advanced-cervical-scan/ 2022-11-09T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/GTI_logo_2021-UKX3La.jpeg https://medicaex.com/businesswire/global-poultry-healthcare-market-research-report-2022-focus-on-vaccines-parasiticides-anti-infectives-medical-feed-additives-forecasts-to-2026-2031-researchandmarkets-com/ 2022-11-09T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-G9mxg3.jpeg https://medicaex.com/businesswire/global-precision-medicine-market-report-2022-collaborations-partnerships-between-major-players-fuel-sector-researchandmarkets-com/ 2022-11-09T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ffbOSX.jpeg https://medicaex.com/businesswire/global-specialty-pharmaceuticals-market-report-2022-attractive-prospects-for-biopharmaceutical-companies-from-both-business-and-medical-innovation-perspectives-drive-growth-researchandmarkets-com/ 2022-11-09T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KyvkB0.jpeg https://medicaex.com/businesswire/cell-free-protein-expression-global-market-report-2022-rising-research-and-development-activities-by-market-players-drives-sector-forward-researchandmarkets-com/ 2022-11-09T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-nKV6UY.jpeg https://medicaex.com/businesswire/us-patent-issued-for-exactechs-predict-first-machine-learning-based-software-that-informs-surgeons-with-patient-specific-outcome-predictions-after-shoulder-replacement-surgery-2/ 2022-11-09T15:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/web_News_US-Patent-Issued-for-Predict2B2C-First-Machine-Learning-Based-Software-that-Informs-Surgeons-with-Patient-Specific-Outcomes-Predictions-after-Shoulder-Replacement-Surgery_Hero-BRAqTR.jpeg https://medicaex.com/businesswire/citiustech-acquires-wilco-source-expands-specialized-salesforce-capabilities-for-healthcare-life-sciences/ 2022-11-09T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/citiustech_logo-rd7DoE.jpeg https://medicaex.com/businesswire/applied-medical-commemorates-20-years-of-wound-protection-with-its-market-leading-alexis-protector-retractors-2/ 2022-11-09T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alexis_Protectors_and_Systems-VtU04B.jpeg https://medicaex.com/businesswire/us-patent-issued-for-exactechs-predict-first-machine-learning-based-software-that-informs-surgeons-with-patient-specific-outcome-predictions-after-shoulder-replacement-surgery/ 2022-11-09T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/web_News_US-Patent-Issued-for-Predict2B2C-First-Machine-Learning-Based-Software-that-Informs-Surgeons-with-Patient-Specific-Outcomes-Predictions-after-Shoulder-Replacement-Surgery_Hero-U8OPbe.jpeg https://medicaex.com/businesswire/hemodialysis-and-peritoneal-dialysis-global-market-report-2022-rising-prevalence-of-kidney-disease-boosts-growth-researchandmarkets-com/ 2022-11-09T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-vwDlyO.jpeg https://medicaex.com/businesswire/applied-medical-commemorates-20-years-of-wound-protection-with-its-market-leading-alexis-protector-retractors/ 2022-11-09T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alexis_Protectors_and_Systems-zkddkO.jpeg https://medicaex.com/businesswire/worldwide-rheometer-viscometer-industry-to-2028-growth-of-the-petrochemical-and-material-manufacturing-industries-is-driving-factor-researchandmarkets-com/ 2022-11-09T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Prri2G.jpeg https://medicaex.com/businesswire/docgo-announces-upcoming-participation-in-four-investor-conferences/ 2022-11-09T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-Bg8bZu.jpeg